South Hall 2
Wed, 30.03.2022
18:15 - 19:45
Calendar Export
Share
Takeda - Novel therapies for EGFR exon 20 insertions and ALK-positive NSCLC: Developments and implications
(ID 35)
Time
18:15 - 19:45
Location
South Hall 2
Date
Wed, 30.03.2022
Takeda - Novel therapies for EGFR exon 20 insertions and ALK-positive NSCLC: Developments and implications
Industry Satellite Symposium
Calendar Export
Welcome and introduction
(ID 284)
Lecture Time
18:15 - 18:20
Speakers
Martin Reck, Grosshansdorf, DE
Session Name
Takeda - Novel therapies for EGFR exon 20 insertions and ALK-positive NSCLC: Developments and implications
Location
South Hall 2, Prague Congress Centre, Prag, Czech Republic
Date
Wed, 30.03.2022
Time
18:15 - 19:45
Takeda - Novel therapies for EGFR exon 20 insertions and ALK-positive NSCLC: Developments and implications
Industry Satellite Symposium
Calendar Export
Precision medicine in NSCLC: From biomarker testing to therapy selection
(ID 285)
Lecture Time
18:20 - 18:35
Speakers
Martin Reck, Grosshansdorf, DE
Session Name
Takeda - Novel therapies for EGFR exon 20 insertions and ALK-positive NSCLC: Developments and implications
Location
South Hall 2, Prague Congress Centre, Prag, Czech Republic
Date
Wed, 30.03.2022
Time
18:15 - 19:45
Takeda - Novel therapies for EGFR exon 20 insertions and ALK-positive NSCLC: Developments and implications
Industry Satellite Symposium
Calendar Export
Emerging therapies for advanced NSCLC With EGFR Exon 20 insertion mutations: Developments and implications
(ID 286)
Lecture Time
18:35 - 19:00
Speakers
Maurice PĂ©rol, Lyon, FR
Session Name
Takeda - Novel therapies for EGFR exon 20 insertions and ALK-positive NSCLC: Developments and implications
Location
South Hall 2, Prague Congress Centre, Prag, Czech Republic
Date
Wed, 30.03.2022
Time
18:15 - 19:45
Takeda - Novel therapies for EGFR exon 20 insertions and ALK-positive NSCLC: Developments and implications
Industry Satellite Symposium
Calendar Export
Frontline treatment of ALK-Positive NSCLC: Therapy considerations and selection
(ID 287)
Lecture Time
19:00 - 19:25
Speakers
Sanjay Popat, London, GB
Session Name
Takeda - Novel therapies for EGFR exon 20 insertions and ALK-positive NSCLC: Developments and implications
Location
South Hall 2, Prague Congress Centre, Prag, Czech Republic
Date
Wed, 30.03.2022
Time
18:15 - 19:45
Takeda - Novel therapies for EGFR exon 20 insertions and ALK-positive NSCLC: Developments and implications
Industry Satellite Symposium
Calendar Export
Live Q&A / discussion
(ID 288)
Lecture Time
19:25 - 19:43
Session Name
Takeda - Novel therapies for EGFR exon 20 insertions and ALK-positive NSCLC: Developments and implications
Location
South Hall 2, Prague Congress Centre, Prag, Czech Republic
Date
Wed, 30.03.2022
Time
18:15 - 19:45
Takeda - Novel therapies for EGFR exon 20 insertions and ALK-positive NSCLC: Developments and implications
Industry Satellite Symposium
Calendar Export
Concluding remarks
(ID 289)
Lecture Time
19:43 - 19:45
Speakers
Martin Reck, Grosshansdorf, DE
Session Name
Takeda - Novel therapies for EGFR exon 20 insertions and ALK-positive NSCLC: Developments and implications
Location
South Hall 2, Prague Congress Centre, Prag, Czech Republic
Date
Wed, 30.03.2022
Time
18:15 - 19:45